Mutant MYBPC3 gene and application thereof in preparation of hypertrophic cardiomyopathy detection kit
A technology for hypertrophic cardiomyopathy and detection kits, applied in the fields of human genetics and medical cardiovascular, to achieve the effect of reducing the birth of children
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 2
[0051] Embodiment 2-Hypertrophic cardiomyopathy detection kit
[0052] This embodiment provides a kit for detecting the heterozygous missense variation of the human MYBPC3 gene c.3312_3313insGG, including 2×Taq MasterMix (Dye), primers capable of detecting the mutated MYBPC3 gene, etc. The specific composition of the kit is shown in Table 3 below Show.
[0053] The specific steps for using this kit to screen patients with the c.3312_3313insGG MYBPC3 gene mutation are: extract the DNA of the test subject according to the steps in Example 1, and then use the designed primer combination (SEQ ID NO: 5 and SEQ ID NO: 6) The MYBPC3 gene was amplified to obtain a PCR product, and finally the PCR product was sequenced. The reference sequence obtained from the NCBI (https: / / www.ncbi.nlm.nih.gov / ) database is compared with the sequencing results to determine whether the subject’s MYBPC3 gene carries the c.3312_3313insGG heterozygous missense mutation, and to assist in clinical diagnosi...
Embodiment 3
[0056] Example 3 Mutation verification for normal people outside the family line
[0057] Referring to the method of Example 1 or using the hypertrophic cardiomyopathy detection kit of Example 2, 657 cases of unrelated normal people of the same race (i.e. normal people outside the family) were tested for the c.3312_3313insGG mutation site of the MYBPC3 gene, and the results were all failed The mutation was detected.
[0058] The results show that the c.3312_3313insGG heterozygous missense mutation of the MYBPC3 gene can lead to p.Ter173Gly changes in the protein encoded by the MYBPC3 gene, and the MYBPC3 gene is a known disease-causing gene, which once again proves that the c.3312_3313insGG heterozygous mutation of the MYBPC3 gene Missense variants are pathogenic variants.
PUM

Abstract
Description
Claims
Application Information

- R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com